These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17305585)

  • 1. myo-Inositol monophosphatase: a challenging target for mood stabilising drugs.
    Miller DJ; Allemann RK
    Mini Rev Med Chem; 2007 Feb; 7(2):107-13. PubMed ID: 17305585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of inositol monophosphatase.
    Fauroux CM; Freeman S
    J Enzyme Inhib; 1999; 14(2):97-108. PubMed ID: 10445037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R; Parthasarathy R
    Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An automated high volume assay to screen for inhibitors of myo-inositol monophosphatase from microbial fermentation broths.
    Vincendon P; Corti E; Guindani A; Brunati C; Sponga F; Stefanelli S; Denaro M; Pelton P; Ganzhorn A; Islam K
    J Antibiot (Tokyo); 1996 Jul; 49(7):710-2. PubMed ID: 8784438
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of inositol monophosphatase in Saccharomyces cerevisiae.
    Murray M; Greenberg ML
    Mol Microbiol; 1997 Aug; 25(3):541-6. PubMed ID: 9302016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of myo-inositol monophosphatase, ATCC 20928 factors A and C. Isolation, physico-chemical characterization and biological properties.
    Stefanelli S; Sponga F; Ferrari P; Sottani C; Corti E; Brunati C; Islam K
    J Antibiot (Tokyo); 1996 Jul; 49(7):611-6. PubMed ID: 8784418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
    Gill R; Mohammed F; Badyal R; Coates L; Erskine P; Thompson D; Cooper J; Gore M; Wood S
    Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):545-55. PubMed ID: 15858264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol monophosphatase inhibitors--lithium mimetics?
    Atack JR
    Med Res Rev; 1997 Mar; 17(2):215-24. PubMed ID: 9057165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and regulation of inositol monophosphatase activity in Mycobacterium smegmatis.
    Nigou J; Besra GS
    Biochem J; 2002 Jan; 361(Pt 2):385-90. PubMed ID: 11772411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.
    Fujita S; Ohnishi T; Okuda S; Kobayashi R; Fukuno S; Furuta D; Kikuchi T; Yoshikawa T; Fujita N
    J Mol Model; 2011 Oct; 17(10):2559-67. PubMed ID: 21213002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and properties of 6-substituted cyclohexane-1,2,4-triol derivatives: mechanistic probes for the inositol monophosphatase reaction.
    Schulz J; Wilkie J; Beaton MW; Miller DJ; Gani D
    Biochem Soc Trans; 1998 Aug; 26(3):315-22. PubMed ID: 9765871
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic characterization of enzyme forms involved in metal ion activation and inhibition of myo-inositol monophosphatase.
    Strasser F; Pelton PD; Ganzhorn AJ
    Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):585-93. PubMed ID: 7733900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncompetitive inhibition of inositol monophosphatase by K-76 monocarboxylic acid.
    Pachter JA
    Mol Pharmacol; 1991 Jul; 40(1):107-11. PubMed ID: 1649963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
    Atack JR; Broughton HB; Pollack SJ
    Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of myo-inositol monophosphatase in Alzheimer's disease brains.
    Shimohama S; Tanino H; Sumida Y; Tsuda J; Fujimoto S
    Neurosci Lett; 1998 Apr; 245(3):159-62. PubMed ID: 9605480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A safe lithium mimetic for bipolar disorder.
    Singh N; Halliday AC; Thomas JM; Kuznetsova OV; Baldwin R; Woon EC; Aley PK; Antoniadou I; Sharp T; Vasudevan SR; Churchill GC
    Nat Commun; 2013; 4():1332. PubMed ID: 23299882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of the phosphate group in mechanism-based inhibitors of inositol monophosphatase leads to unusual inhibitory activity.
    Miller DJ; Bashir-Uddin Surfraz M; Akhtar M; Gani D; Allemann RK
    Org Biomol Chem; 2004 Mar; 2(5):671-88. PubMed ID: 14985807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
    Faraci WS; Zorn SH; Bakker AV; Jackson E; Pratt K
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):369-74. PubMed ID: 8387266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The purification and properties of myo-inositol monophosphatase from bovine brain.
    Gee NS; Ragan CI; Watling KJ; Aspley S; Jackson RG; Reid GG; Gani D; Shute JK
    Biochem J; 1988 Feb; 249(3):883-9. PubMed ID: 2833231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. myo-Inositol monophosphatase in the brain has zinc ion-dependent tyrosine phosphatase activity.
    Fujimoto S; Tsuda J; Kawakami N; Tanino H; Shimohama S
    Gen Pharmacol; 1998 Sep; 31(3):469-75. PubMed ID: 9703222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.